Table 2.

Quality outcome measures in RightStart-enrolled patients compared to non-RightStart patients at 120 d

RightStart GroupControl GroupP Value
Access
    AVF (%)32.6 (0.5)23.4 (0.4)
    Catheter (%)51.8 (0.5)47.4 (0.5)
    Graft (%)12.0 (0.3)13.9 (0.3)
    Unknown (%)3.5 (0.1)15.4 (0.3)<0.0001
Hemoglobin
    Concentration (g/dl)12.3 (0.02)12.2 (0.02)0.002
    Percentage within 11–12 g/dl22.4 (0.4)19.7 (0.4)0.002
Iron saturation
    Level (%)25 (0.2)24 (0.2)<0.0001
    Percentage within 20–50%54.9 (0.5)47.1 (0.5)<0.0001
Albumin
    Concentration (g/dl)3.64 (0.007)3.57 (0.008)<0.0001
    Percentage ≥4.0 g/dl26.0 (0.4)22.2 (0.4)<0.0001
    Percentage ≥3.5 g/dl71.5 (0.4)63.4 (0.5)<0.0001
Phosphorus
    Concentration (mg/dl)5.4 (0.02)5.5 (0.02)0.008
    Percentage within 3.5–5.5 mg/dl52.4 (0.5)45.4 (0.5)<0.0001
Dialysis adequacy
    eKt/V1.36 (0.006)1.32 (0.006)<0.0001
    Percentage eKt/V ≥1.266.0 (0.5)53.5 (0.5)<0.0001
EPO (% use)83.0 (0.4)81.6 (0.4)0.08
Vitamin D (% use)60.1 (0.5)55.4 (0.5)<0.0001
Episodes of foot checks (in first 120 d)1.9 (0.05)0.5 (0.03)<0.0001
Days to first laboratory draw3.23 (0.1)7.19 (0.3)<0.0001
Days to first EPO order8.42 (0.3)12.91 (0.4)<0.0001
  • Values are mean (SE).

  • EPO, erythropoietin.